TPIDB > Principal Investigator
Principal Investigator
更新時間：2025-03-10
邱瀚模CHIU, HAN-MO
- Co-Principal Investigator
- Clinical Trial Experience (year) 12 years 9 個月
Publication
56Publications
31
Kuo CY, Wu JW, Yeh JH, Wang WL, Tu CH, Chiu HM, Liao WC. Implementing precision medicine in endoscopy practice. J Gastroenterol Hepatol. 2022 Aug;37(8):1455-1468. doi: 10.1111/jgh.15933. Epub 2022 Jul 13. PMID: 35778863.
32
Lee YC, Chiang TH, Chiu HM, Wu MS, Yeh YP, Hsiu-Hsi Chen T; Collaborators of the Taiwan Community-Based Integrated Screening Group. Community-Based Gastric Cancer Screening Coupled With a National Colorectal Cancer Screening Program: Baseline Results. Gastroenterology. 2021 May;160(6):2159-2161.e4. doi: 10.1053/j.gastro.2021.01.008. Epub 2021 Jan 11. PMID: 33444571.
33
Lee YC, Fann JC, Chiang TH, Chuang SL, Chen SL, Chiu HM, Yen AM, Chiu SY, Hsu CY, Hsu WF, Wu MS, Chen HH. Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests. Clin Gastroenterol Hepatol. 2019 Jun;17(7):1332-1340.e3. doi: 10.1016/j.cgh.2018.10.041. Epub 2018 Nov 1. PMID: 30391435.
34
Lee YC, Hsu CY, Chen SL, Yen AM, Chiu SY, Fann JC, Chuang SL, Hsu WF, Chiang TH, Chiu HM, Wu MS, Chen HH. Effects of screening and universal healthcare on long-term colorectal cancer mortality. Int J Epidemiol. 2019 Apr 1;48(2):538-548. doi: 10.1093/ije/dyy182. PMID: 30184208; PMCID: PMC6469303.
35
Liao PH, Chiang HL, Shun CT, Hang JF, Chiu HM, Wu MS, Lin CH. Colonic Leucine-Rich Repeat Kinase 2 Expression Is Increased and Associated With Disease Severity in Patients With Parkinson's Disease. Front Aging Neurosci. 2022 Jan 17;13:819373. doi: 10.3389/fnagi.2021.819373. PMID: 35126095; PMCID: PMC8812574.
36
Lin CH, Lin HY, Ho EP, Ke YC, Cheng MF, Shiue CY, Wu CH, Liao PH, Hsu AY, Chu LA, Liu YD, Lin YH, Tai YC, Shun CT, Chiu HM, Wu MS. Reply to: Mild Chronic Colitis Triggers Parkinsonism in LRRK2 Mutant Mice through Activating TNF-α Pathway. Mov Disord. 2022 Mar;37(3):665-666. doi: 10.1002/mds.28947. Epub 2022 Jan 29. PMID: 35092086; PMCID: PMC9306538.
37
Lin CH, Lin HY, Ho EP, Ke YC, Cheng MF, Shiue CY, Wu CH, Liao PH, Hsu AY, Chu LA, Liu YD, Lin YH, Tai YC, Shun CT, Chiu HM, Wu MS. Reply to: Mild Chronic Colitis Triggers Parkinsonism in LRRK2 Mutant Mice through Activating TNF-α Pathway. Mov Disord. 2022 Mar;37(3):665-666. doi: 10.1002/mds.28947. Epub 2022 Jan 29. PMID: 35092086; PMCID: PMC9306538.
38
Nakajima T, Sakamoto T, Hori S, Yamada S, Ikematsu H, Harada K, Chiu HM, Kiriyama S, Michida T, Hotta K, Sakamoto N, Abe T, Chino A, Fukuzawa M, Kobayashi N, Fukase K, Matsuda T, Murakami Y, Ishikawa H, Saito Y. Optimal surveillance interval after piecemeal endoscopic mucosal resection for large colorectal neoplasia: a multicenter randomized controlled trial. Surg Endosc. 2022 Jan;36(1):515-525. doi: 10.1007/s00464-021-08311-6. Epub 2021 Feb 10. PMID: 33569725.
39
Onyoh EF, Hsu WF, Chang LC, Lee YC, Wu MS, Chiu HM. The Rise of Colorectal Cancer in Asia: Epidemiology, Screening, and Management. Curr Gastroenterol Rep. 2019 Jul 10;21(8):36. doi: 10.1007/s11894-019-0703-8. PMID: 31289917.
40
Peng SM, Chiu HM, Jen HH, Hsu CY, Chen SL, Chiu SY, Yen AM, Fann JC, Lee YC, Chen HH. Quantile-based fecal hemoglobin concentration for assessing colorectal neoplasms with 1,263,717 Taiwanese screenees. BMC Med Inform Decis Mak. 2019 May 2;19(1):94. doi: 10.1186/s12911-019-0812-1. PMID: 31046760; PMCID: PMC6498550.
